315 related articles for article (PubMed ID: 622235)
1. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
Notation AD; Tagatz GE; Steffes MW
Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
[TBL] [Abstract][Full Text] [Related]
2. HMG-HCG therapy in patients with hypergonadotropic ovarian anovulation: one pregnancy case report and ovulation and pregnancy rate.
Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K
Int J Fertil; 1982; 27(2):100-4. PubMed ID: 6126442
[TBL] [Abstract][Full Text] [Related]
3. Plasma hormones in human gonadotropin induced ovulation.
Wu CH
Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
[TBL] [Abstract][Full Text] [Related]
4. Ovulation monitored by serum 17 beta-estradiol and ultrasound: differential ovarian response to human gonadotropins in various anovulatory states.
Padova G; Briguglia G; Tita P; Arpi ML; Munguira ME; Cafiso F; Cianci A; Ettore G; Pezzino V
Acta Eur Fertil; 1988; 19(5):283-6. PubMed ID: 3150888
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
Muechler EK; Kohler D; Huang KE
Int J Fertil; 1981; 26(4):273-8. PubMed ID: 6120908
[TBL] [Abstract][Full Text] [Related]
7. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
[TBL] [Abstract][Full Text] [Related]
8. Pre-ovulatory plasma levels of 17beta-oestradiol (E2) and conception in patients treated with gonadotrophins.
Ferin J; Thomas K; De Hertogh R
Acta Endocrinol Suppl (Copenh); 1977; 214():33-42. PubMed ID: 268747
[TBL] [Abstract][Full Text] [Related]
9. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
[TBL] [Abstract][Full Text] [Related]
10. [The studies on the individualized treatment and hormonal patterns during the administration of HMG-HCG in anovulatory women (author's transl)].
Kooguchi J; Uemura T; Shiojima Y; Iwasaki H
Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):777-85. PubMed ID: 6787830
[TBL] [Abstract][Full Text] [Related]
11. Ovulation induction with gonadotropins in women with polycystic ovary disease.
Kupferminc MJ; Lessing JB; Peyser MR
J Reprod Med; 1991 Jan; 36(1):61-4. PubMed ID: 1901089
[TBL] [Abstract][Full Text] [Related]
12. Ovulation induction with human menopausal gonadotropins.
Diamond MP; Wentz AC
Obstet Gynecol Surv; 1986 Aug; 41(8):480-90. PubMed ID: 3090489
[TBL] [Abstract][Full Text] [Related]
13. Induction of ovulation and pregnancy in twenty-six patients with primary hypogonadotropic amenorrhea.
Batrinos ML; Panitsa-Faflia C
Int J Fertil; 1980; 25(4):257-66. PubMed ID: 6114047
[TBL] [Abstract][Full Text] [Related]
14. Restoration of the ovarian response to gonadotropins in patients after molar abortion.
Miyake A; Aono T; Kurachi H; Tsutsumi H; Kurachi K
Obstet Gynecol; 1981 Nov; 58(5):566-8. PubMed ID: 6795552
[TBL] [Abstract][Full Text] [Related]
15. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
Ellenbogen A; David H; Libal Y; Ballas S
Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
[TBL] [Abstract][Full Text] [Related]
16. Influence of serum progesterone levels at the time of hCG on the release of ova during hMG cycles.
Check JH; Adelson HG; Stern J; Lauer C
Int J Fertil; 1992; 37(2):103-5. PubMed ID: 1349590
[TBL] [Abstract][Full Text] [Related]
17. [Critical evaluation of clinical and hormonal parameters for the optimal timing of induction of ovulation with gonadotropins (author's transl)].
Hardt W; Schmidt-Gollwitzer M; Boquol E; Stadler C; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1977 Nov; 37(11):925-33. PubMed ID: 924102
[TBL] [Abstract][Full Text] [Related]
18. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
Vrtovec HM; Tomazevic T
J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
[TBL] [Abstract][Full Text] [Related]
19. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
Olson JL; Rebar RW; Schreiber JR; Vaitukaitis JL
Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
[TBL] [Abstract][Full Text] [Related]
20. [Endocrine evaluation of induction of ovulation with pulsatile and continuous administration of human menopausal gonadotropin (hMG) in anovulatory women].
Masaoka K; Kitazawa M; Niibe T; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):73-80. PubMed ID: 3081669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
